Quetiapine Impurity 27 | CAS 1141-88-4 - Request Quote
Quetiapine Impurity 27
| SZ CAT No: | SZ-Q001083 |
| CAS No | 1141-88-4 |
| Mol.F. | C12H12N2S2 |
| Mol.Wt. | 248.4 |
| Inv. Status | Synthesis on demand |
| Rel. CAS No | 878747-00-3 (HCl salt) ; 93073-03-1 (HBr salt) |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Quetiapine Impurity 27 is chemically 2,2'-Disulfanediyldianiline. Quetiapine Impurity 27 is supplied with detailed characterization data compliant with regulatory guideline. Quetiapine Impurity 27 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Quetiapine.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 1141-88-4
Purchase 1141-88-4
Order 1141-88-4
Enquire 1141-88-4
price of 1141-88-4
1141-88-4 Supplier
1141-88-4 Manufacturer
1141-88-4 Exporter
buy high quality Quetiapine Impurity 27
Purchase Quetiapine Impurity 27
Quetiapine Impurity 27 suppliers
Quetiapine Impurity 27 manufacturers
Quetiapine Impurity 27 price
Order Quetiapine Impurity 27
Enquire Quetiapine Impurity 27
Quetiapine Impurity 27 cost
Quetiapine Impurity 27 Supplier
Quetiapine Impurity 27 Distributor
Quetiapine Impurity 27 for Method Validation
Quetiapine Reference Standard
Quetiapine Impurity 27 for ANDA Filing
Quetiapine Impurity 27 for Forced Degradation Studies
Quetiapine Impurity 27 Identification Standards
Quetiapine Impurity 27 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.